News

16.02.20 Medannex shortlisted in two categories at Scotland’s Life Sciences Awards
02.11.19 Dr Stefan Symeonides to guide Medannex’s Phase I trial preparation
02.10.19 Medannex begins cell line development at FUJIFILM Diosynth
14.08.19 Ian Abercrombie joins Medannex as Chief Executive Officer
18.07.19 Medannex announces £11 million Series B investment
02.02.19 Medannex awarded £200,000 by Innovate UK for lupus therapeutic development
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6